ZNF449 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.26559995606135E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.28020000045304E-07 |
Normal-vs-Stage2 |
3.971800E-02 |
Normal-vs-Stage3 |
1.180990E-01 |
Normal-vs-Stage4 |
6.980600E-01 |
Stage1-vs-Stage2 |
3.847600E-01 |
Stage1-vs-Stage3 |
2.028400E-02 |
Stage1-vs-Stage4 |
1.280390E-03 |
Stage2-vs-Stage3 |
1.132440E-01 |
Stage2-vs-Stage4 |
3.526400E-02 |
Stage3-vs-Stage4 |
2.093200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.70999999610433E-08 |
Normal-vs-AfricanAmerican |
4.780500E-04 |
Normal-vs-Asian |
7.626400E-01 |
Caucasian-vs-AfricanAmerican |
3.553400E-01 |
Caucasian-vs-Asian |
1.903990E-01 |
AfricanAmerican-vs-Asian |
2.839900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.10610000234746E-08 |
Normal-vs-Female |
2.23029999999458E-05 |
Male-vs-Female |
2.829800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.962200E-03 |
Normal-vs-Extreme_Weight |
3.405200E-04 |
Normal-vs-Obese |
1.175360E-04 |
Normal-vs-Extreme_Obese |
9.743800E-03 |
Normal_Weight-vs-Extreme_Weight |
8.240600E-01 |
Normal_Weight-vs-Obese |
7.110100E-02 |
Normal_Weight-vs-Extreme_Obese |
3.098200E-01 |
Extreme_Weight-vs-Obese |
7.596400E-02 |
Extreme_Weight-vs-Extreme_Obese |
3.652800E-01 |
Obese-vs-Extreme_Obese |
6.574800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.241200E-04 |
Normal-vs-Age(41-60Yrs) |
1.86310000760415E-09 |
Normal-vs-Age(61-80Yrs) |
5.58179999999853E-05 |
Normal-vs-Age(81-100Yrs) |
5.778200E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.202010E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.950600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.480380E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.205840E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.785800E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.636400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.91849869324301E-11 |
Normal-VS-Type2 PRCC |
4.177800E-01 |
Normal-VS-KIRP CIMP |
5.960400E-01 |
Normal-VS-Unclassified PRCC |
2.161700E-03 |
Type1 PRCC-VS-Type2 PRCC |
1.05389996729599E-09 |
Type1 PRCC-VS-KIRP CIMP |
4.794300E-02 |
Type1 PRCC-VS-Unclassified PRCC |
7.269400E-01 |
Type2 PRCC-VS-KIRP CIMP |
8.801600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
5.159100E-03 |
KIRP CIMP-VS-Unclassified PRCC |
2.457700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.400390E-02 |
Normal-vs-N1 |
1.472210E-01 |
Normal-vs-N2 |
3.076200E-01 |
N0-vs-N1 |
6.541800E-01 |
N0-vs-N2 |
8.185600E-01 |
N1-vs-N2 |
9.848000E-01 |
|
|